US FDA grants tentative nod to Dr Reddy's twice-yearly HIV prevention drug
The tentative approval for generic lenacapavir is expected to accelerate affordable access to the twice-yearly HIV prevention injection across 120 countries outside the US.
The tentative approval for generic lenacapavir is expected to accelerate affordable access to the twice-yearly HIV prevention injection across 120 countries outside the US.
